JPH11246376A - Composition for oral cavity - Google Patents
Composition for oral cavityInfo
- Publication number
- JPH11246376A JPH11246376A JP10063992A JP6399298A JPH11246376A JP H11246376 A JPH11246376 A JP H11246376A JP 10063992 A JP10063992 A JP 10063992A JP 6399298 A JP6399298 A JP 6399298A JP H11246376 A JPH11246376 A JP H11246376A
- Authority
- JP
- Japan
- Prior art keywords
- zinc
- anethole
- polyhydric alcohol
- composition
- fluoride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 210000000214 mouth Anatomy 0.000 title abstract 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 claims abstract description 26
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 14
- 229940011037 anethole Drugs 0.000 claims abstract description 13
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 150000003752 zinc compounds Chemical class 0.000 claims abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000811 xylitol Substances 0.000 claims abstract description 4
- 235000010447 xylitol Nutrition 0.000 claims abstract description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 4
- 229960002675 xylitol Drugs 0.000 claims abstract description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 3
- 239000000845 maltitol Substances 0.000 claims abstract description 3
- 235000010449 maltitol Nutrition 0.000 claims abstract description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 3
- 229940035436 maltitol Drugs 0.000 claims abstract description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 3
- 239000000600 sorbitol Substances 0.000 claims abstract description 3
- 235000010356 sorbitol Nutrition 0.000 claims abstract description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910052731 fluorine Inorganic materials 0.000 claims abstract 2
- 239000011737 fluorine Substances 0.000 claims abstract 2
- 238000002156 mixing Methods 0.000 claims description 4
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 claims description 2
- 150000002222 fluorine compounds Chemical class 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 208000006558 Dental Calculus Diseases 0.000 abstract description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 abstract description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 abstract description 4
- 239000000606 toothpaste Substances 0.000 abstract description 4
- 229940034610 toothpaste Drugs 0.000 abstract description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 abstract description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 abstract description 3
- 239000003082 abrasive agent Substances 0.000 abstract description 3
- 239000003945 anionic surfactant Substances 0.000 abstract description 3
- 239000004088 foaming agent Substances 0.000 abstract description 3
- 239000003755 preservative agent Substances 0.000 abstract description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 abstract description 2
- 208000002925 dental caries Diseases 0.000 abstract description 2
- 239000011698 potassium fluoride Substances 0.000 abstract description 2
- 235000003270 potassium fluoride Nutrition 0.000 abstract description 2
- 230000002335 preservative effect Effects 0.000 abstract description 2
- 239000011775 sodium fluoride Substances 0.000 abstract description 2
- 235000013024 sodium fluoride Nutrition 0.000 abstract description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 abstract description 2
- 239000004246 zinc acetate Substances 0.000 abstract description 2
- 235000013904 zinc acetate Nutrition 0.000 abstract description 2
- 239000011592 zinc chloride Substances 0.000 abstract description 2
- 235000005074 zinc chloride Nutrition 0.000 abstract description 2
- 239000011746 zinc citrate Substances 0.000 abstract description 2
- 235000006076 zinc citrate Nutrition 0.000 abstract description 2
- 229940068475 zinc citrate Drugs 0.000 abstract description 2
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 description 11
- 239000000551 dentifrice Substances 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 235000019606 astringent taste Nutrition 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 208000025371 Taste disease Diseases 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019656 metallic taste Nutrition 0.000 description 4
- 206010006326 Breath odour Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229940091249 fluoride supplement Drugs 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- -1 polyoxyethylene Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000005417 aminobenzoic acid derivatives Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- MFGZXPGKKJMZIY-UHFFFAOYSA-N ethyl 5-amino-1-(4-sulfamoylphenyl)pyrazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)C=NN1C1=CC=C(S(N)(=O)=O)C=C1 MFGZXPGKKJMZIY-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical class C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940084560 sanguinarine Drugs 0.000 description 1
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical class [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- 229940057977 zinc stearate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、亜鉛化合物を含有
する抗う蝕用、歯石予防用や口臭予防用口腔用組成物に
関し、亜鉛の渋味、苦みや金属味が改良され、使用感の
良好な口腔用組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an oral composition containing a zinc compound for preventing dental caries, for preventing tartar and for preventing bad breath, which has improved astringency, bitterness and metallic taste of zinc, and has a good feeling in use. Oral compositions.
【0002】[0002]
【従来技術および問題点】従来より、亜鉛化合物を、口
臭予防や歯石防止の目的で口腔用組成物に配合すること
が知られている。また、その亜鉛化合物は一般的に渋み
を与えることが知られており、特開昭63−8324で
はポリオキシエチレン硬化ヒマシ油とl−メントールと
を併用することにより渋みが改善されることが開示され
ている。2. Description of the Related Art Conventionally, it has been known that a zinc compound is added to an oral composition for the purpose of preventing bad breath and tartar. In addition, it is known that the zinc compound generally gives astringency, and JP-A-63-8324 discloses that the combined use of polyoxyethylene hydrogenated castor oil and l-menthol improves the astringency. Have been.
【0003】[0003]
【発明が解決しようとする課題】これまで示された方法
では渋みの改善効果が十分でなく、亜鉛独特の苦みおよ
び金属味を感じたり、使用感が良くないという欠点が残
っている。However, the methods described so far do not have a sufficient effect of reducing astringency, and have the disadvantage that zinc has a bitterness and metallic taste unique to zinc, and the feeling of use is poor.
【0004】[0004]
【課題を解決するための手段】本発明者らは、上記の事
情を鑑み、鋭意検討を行った結果、亜鉛化合物を含有し
た口腔用組成物において、多価アルコールとアネトール
とをある一定の割合で配合することにより、意外にも亜
鉛化合物の金属味が改善されることがわかった。本発明
の目的は亜鉛を含有する抗齲蝕用、歯石予防用や口臭予
防用口腔用組成物に関し、亜鉛の渋味、苦みや金属味が
改良され、使用感の良好な口腔用組成物を提供すること
にある。Means for Solving the Problems The present inventors have conducted intensive studies in view of the above circumstances, and as a result, have found that a polyhydric alcohol and anethole can be contained in an oral composition containing a zinc compound at a certain ratio. It was surprisingly found that the metal taste of the zinc compound was unexpectedly improved by blending in the formula (1). An object of the present invention relates to an anti-caries, tartar-preventing, or bad breath-preventing oral composition containing zinc, which provides an oral composition having improved astringency, bitterness and metallic taste of zinc and a good feeling in use. Is to do.
【0005】[0005]
【発明の実施の形態】本発明で使用される亜鉛化合物は
特に限定されないが、例えば塩化亜鉛、クエン酸亜鉛、
酢酸亜鉛、乳酸亜鉛、サリチル酸亜鉛、硫酸亜鉛、ステ
アリン酸亜鉛、酸化亜鉛等を用いることができる。な
お、これらは単独でも、2種以上を併用しても良い。BEST MODE FOR CARRYING OUT THE INVENTION The zinc compound used in the present invention is not particularly restricted but includes, for example, zinc chloride, zinc citrate,
Zinc acetate, zinc lactate, zinc salicylate, zinc sulfate, zinc stearate, zinc oxide, and the like can be used. These may be used alone or in combination of two or more.
【0006】本発明で使用するアネトールは、天然由
来、合成のいずれでもよく、その配合量は、0.01〜
1重量%が好ましい。配合量が0.01重量%未満であ
ると効果が期待できず、また、1重量%を越えて配合す
るとアネトールの香気が強すぎてアネトール自体の苦味
が生じ、使用した際良好な使用感が得られない。[0006] The anethole used in the present invention may be of natural origin or synthetic.
1% by weight is preferred. If the amount is less than 0.01% by weight, no effect can be expected. If the amount is more than 1% by weight, the aroma of anethole is too strong to cause bitterness of the anethole itself, resulting in a good feeling of use when used. I can't get it.
【0007】また、多価アルコールとしてはソルビトー
ル、キシリトール、グリセリンおよびポリエチレングリ
コール、マルチトール、パラチノースなどが挙げられ、
一種あるいは二種以上を組合わせて配合することができ
る。多価アルコールの配合量は特に限定されないが、本
発明においては、アネトールと多価アルコールとの比が
重要であり、その比が1:10〜1:1000が好まし
く、特に1:100〜1:900が好適である。その範
囲を外れると、金属味の改善効果があまり期待できず、
多価アルコールが多すぎると、使用時に多価アルコール
特有の灼熱感が強く使用感が好ましくない。The polyhydric alcohols include sorbitol, xylitol, glycerin and polyethylene glycol, maltitol, palatinose, etc.
One type or a combination of two or more types can be blended. The blending amount of the polyhydric alcohol is not particularly limited, but in the present invention, the ratio between anethole and the polyhydric alcohol is important, and the ratio is preferably from 1:10 to 1: 1000, particularly preferably from 1: 100 to 1: 1,000. 900 is preferred. Outside of that range, the effect of improving metal taste cannot be expected much,
If the amount of the polyhydric alcohol is too large, the burning sensation peculiar to the polyhydric alcohol at the time of use is so strong that the feeling of use is not preferable.
【0008】本発明で用いるフッ化物は、フッ化ナトリ
ウム、フッ化カリウム、フッ化アンモニウム、フッ化第
一スズ、モノフルオロリン酸ナトリウム、およびモノフ
ルオロリン酸カリウム等が挙げられ、フッ化ナトリウ
ム、モノフルオロリン酸ナトリウム(より好ましいフッ
化物およびその理由)がより好ましい。The fluoride used in the present invention includes sodium fluoride, potassium fluoride, ammonium fluoride, stannous fluoride, sodium monofluorophosphate and potassium monofluorophosphate. Sodium monofluorophosphate (more preferred fluorides and why) is more preferred.
【0009】本発明の口腔用組成物は、その用途に応じ
て、適宜処方され、常法に従って練歯磨、粉歯磨、液状
歯磨、液体歯磨、潤性歯磨、ゲル類、クリーム類、パス
タ類、洗口剤、スプレー、フォーム等の剤形とすること
ができる。他の配合成分は特に限定されるものではな
く、公知の有効成分、研磨剤、湿潤剤、粘結剤、発泡
剤、保存剤、香味剤、pH調整剤等を本発明の効果を損な
わない範囲で配合することができる。[0009] The oral composition of the present invention is appropriately formulated according to its use, and toothpaste, powdered toothpaste, liquid dentifrice, liquid dentifrice, moisturizing dentifrice, gels, creams, pasta, It can be in the form of mouthwash, spray, foam and the like. Other components are not particularly limited, and include known active ingredients, abrasives, wetting agents, binders, foaming agents, preservatives, flavoring agents, pH adjusters, and the like within a range that does not impair the effects of the present invention. Can be blended.
【0010】例えば、フッ化物以外の有効成分としては
以下のものが挙げられる。アミラーゼ、プロテアーゼ、
リゾチーム、デキストラナーゼ等の酵素、サンギナリ
ン、アラントイン、アミノ安息香酸誘導体、ヘキセチジ
ン、クロルヘキシジン塩類、トリクロサン、塩化セチル
ピリジニウムのような抗歯垢剤や抗菌剤、ビタミンB、
C、E等のビタミン類、カリウム、リチウム、ナトリウ
ムの硝酸塩等が挙げられる。For example, the following are examples of the active ingredient other than the fluoride. Amylase, protease,
Lysozyme, enzymes such as dextranase, sanguinarine, allantoin, aminobenzoic acid derivatives, hexetidine, chlorhexidine salts, triclosan, antiplaque agents and antibacterial agents such as cetylpyridinium chloride, vitamin B,
Examples include vitamins such as C and E, and potassium, lithium, and sodium nitrates.
【0011】研磨剤には、無水ケイ酸、アルミナ、アル
ミノシリケート、リン酸水素カルシウム、炭酸カルシウ
ム、リン酸カルシウム、水酸化アルミニウム等が挙げら
れる。粘結剤としてはカルボキシメチルセルロース、メ
チルセルロース、ヒドロキシエチルセルロース、キサン
タンガム、カラギーナン、アラビアガム等が挙げられ
る。Examples of the abrasive include silicic anhydride, alumina, aluminosilicate, calcium hydrogen phosphate, calcium carbonate, calcium phosphate, aluminum hydroxide and the like. Examples of the binder include carboxymethylcellulose, methylcellulose, hydroxyethylcellulose, xanthan gum, carrageenan, and gum arabic.
【0012】発泡剤としては、陰イオン、非イオン、陽
イオン、及び両性界面活性剤が挙げられ、陰イオン性界
面活性剤は、アルキル硫酸系界面活性剤、アミノ酸系界
面活性剤、スルホコハク酸系界面活性剤が挙げられる。
非イオン性界面活性剤は、ポリオキシエチレンポリオキ
シプロピレン共重合体であるプルロニック系界面活性
剤、脂肪酸ジアルカノールアミド系界面活性剤等が挙げ
られる。Examples of the foaming agent include anionic, nonionic, cationic and amphoteric surfactants. Examples of the anionic surfactant include alkylsulfuric acid surfactants, amino acid surfactants, and sulfosuccinic acid surfactants. Surfactants.
Examples of the nonionic surfactant include a pluronic surfactant which is a polyoxyethylene polyoxypropylene copolymer and a fatty acid dialkanolamide surfactant.
【0013】保存剤としては、メチルパラベン、プロピ
ルパラベン、ベンゾエート、安息香酸ナトリウム、パラ
オキシ安息香酸エステル、二酸化チタン等が挙げられ
る。香味剤には、サッカリン塩、デキストロース、アス
パルテーム、キシリトール、ステビアエキス、ペパーミ
ント油、スペアミント油、ハツカ油、オレンジ油、メン
トール、冬緑油が挙げられる。Examples of the preservative include methyl paraben, propyl paraben, benzoate, sodium benzoate, paraoxybenzoate, titanium dioxide and the like. Flavoring agents include saccharin salt, dextrose, aspartame, xylitol, stevia extract, peppermint oil, spearmint oil, hatsuka oil, orange oil, menthol, and winter green oil.
【0014】pH調整剤には、クエン酸及びその塩、リン
酸及びその塩、リンゴ酸及びその塩、グルコン酸及びそ
の塩、マレイン酸及びその塩、アスパラギン酸及びその
塩、コハク酸及びその塩、グルクロン酸及びその塩、フ
マル酸及びその塩、グルタミン酸及びその塩、アジピン
酸及びその塩、塩酸、水酸化アルカリ金属等が挙げられ
る。[0014] pH adjusters include citric acid and its salts, phosphoric acid and its salts, malic acid and its salts, gluconic acid and its salts, maleic acid and its salts, aspartic acid and its salts, succinic acid and its salts , Glucuronic acid and its salts, fumaric acid and its salts, glutamic acid and its salts, adipic acid and its salts, hydrochloric acid, alkali metal hydroxide and the like.
【0015】つぎに、試験例及び実施例を挙げて本発明
をさらに詳しく説明するが、本発明はこれらに限定され
るものではない。実施例中の配合量はいずれも重量%を
意味する。Next, the present invention will be described in more detail with reference to Test Examples and Examples, but the present invention is not limited to these. All of the compounding amounts in the examples mean% by weight.
【0016】試験例 香味評価 表1および表2に示した配合量に従い、常法に従い、亜
鉛化合物、アネトール、多価アルコールを配合した歯磨
剤を調製し、官能評価により、香味について評価した。
結果は表1および表2に示す。Test Examples Flavor Evaluation According to the amounts shown in Tables 1 and 2, a dentifrice containing a zinc compound, anethole and a polyhydric alcohol was prepared according to a conventional method, and the flavor was evaluated by sensory evaluation.
The results are shown in Tables 1 and 2.
【0017】[0017]
【表1】 [Table 1]
【0018】[0018]
【表2】 [Table 2]
【0019】実施例9 常法に従い、以下の処方で練り歯磨剤を調製した。 以上の歯磨剤は良好な使用感を有した。Example 9 A toothpaste was prepared according to a conventional method according to the following formulation. The above dentifrices had a good feeling of use.
【0020】実施例10 常法に従い、以下の処方で水歯磨剤を調製した。 以上の水歯磨剤は良好な使用感を有した。Example 10 A water dentifrice was prepared according to the following formulation according to a conventional method. The above water dentifrices had a good feeling of use.
【0021】実施例11 常法に従い、以下の処方でマウスウォッシュを調製し
た。 以上のマウスウォッシュは良好な使用感を有した。Example 11 A mouthwash was prepared according to the following formulation according to a conventional method. The above mouthwash had a good feeling of use.
【0022】[0022]
【発明の効果】本発明に係る口腔用組成物は、亜鉛化合
物とアネトールおよび多価アルコールを配合し、さらに
アネトールと多価アルコールとの比率を限定することに
より、亜鉛塩の金属味を改善し、使用感の優れた口腔用
組成物を提供することができる。The oral composition according to the present invention improves the metallic taste of zinc salt by blending a zinc compound with anethole and a polyhydric alcohol and further limiting the ratio of anethole to the polyhydric alcohol. Thus, it is possible to provide an oral composition having an excellent feeling in use.
Claims (4)
ルと多価アルコールを配合した口腔用組成物において、
アネトールと多価アルコールの配合比が重量で1:10
〜1:1000であることを特徴とする口腔用組成物。An oral composition comprising a pharmaceutically acceptable zinc compound, anethole and a polyhydric alcohol,
The mixing ratio of anethole and polyhydric alcohol is 1:10 by weight.
1 : 1: 1000.
%であることを特徴とした請求項1項記載の口腔用組成
物。2. The oral composition according to claim 1, wherein the content of said anethole is 0.01 to 1% by weight.
リトール、グリセリンおよびポリエチレングリコール、
マルチトール、パラチノースよりなる群から選ばれた1
種または2種以上である請求第1項記載の口腔用組成
物。3. The method according to claim 2, wherein the polyhydric alcohol is sorbitol, xylitol, glycerin and polyethylene glycol.
1 selected from the group consisting of maltitol and palatinose
The oral composition according to claim 1, wherein the composition is at least one species.
000ppmさらに配合したことを特徴とする請求第1
項記載の口腔用組成物。4. A fluorine compound of 50 to 10 as fluorine.
000 ppm, further comprising:
The oral composition according to the above item.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10063992A JPH11246376A (en) | 1998-02-27 | 1998-02-27 | Composition for oral cavity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10063992A JPH11246376A (en) | 1998-02-27 | 1998-02-27 | Composition for oral cavity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004115468A Division JP2004203894A (en) | 2004-04-09 | 2004-04-09 | Composition for oral cavity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11246376A true JPH11246376A (en) | 1999-09-14 |
Family
ID=13245292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10063992A Pending JPH11246376A (en) | 1998-02-27 | 1998-02-27 | Composition for oral cavity |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH11246376A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006160621A (en) * | 2004-12-03 | 2006-06-22 | Naris Cosmetics Co Ltd | Oral composition for skin |
| JP2017052700A (en) * | 2015-09-07 | 2017-03-16 | ライオン株式会社 | Oral composition |
| US10537506B2 (en) | 2014-12-01 | 2020-01-21 | Colgate-Palmolive Company | Increasing micro-robustness |
Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5793987A (en) * | 1980-09-22 | 1982-06-11 | Richiyaadosonnbitsukusu Inc | Zinc derivatives and use for dental composition |
| JPS61263912A (en) * | 1985-04-16 | 1986-11-21 | コルゲ−ト・パ−モリブ・カンパニ− | Composition for drowning breath odor |
| JPS62223109A (en) * | 1986-01-22 | 1987-10-01 | コルゲ−ト・パ−モリブ・カンパニ− | Stable unit dosage type oral product |
| JPS638324A (en) * | 1986-06-27 | 1988-01-14 | Lion Corp | Composition for oral cavity |
| JPS6345215A (en) * | 1986-06-27 | 1988-02-26 | ブレンダツクス−ヴエルケ エル シユナイダ− ゲゼルシヤフト ミツト ベシユレンクテル ハフツンク ウント コンパニ− | Oral sanitary composition |
| JPS6366115A (en) * | 1986-09-09 | 1988-03-24 | Lion Corp | Composition for oral cavity for deodorizing nicotine |
| JPS63141921A (en) * | 1986-12-04 | 1988-06-14 | Kao Corp | Composition for oral cavity application |
| JPS6438017A (en) * | 1987-06-30 | 1989-02-08 | Union Carbide Corp | Anticaries and antitartar composition containing zeolitic zinc cation |
| JPH02223511A (en) * | 1988-11-09 | 1990-09-05 | Procter & Gamble Co:The | Composition for buccal application |
| US5002970A (en) * | 1981-07-31 | 1991-03-26 | Eby Iii George A | Flavor masked ionizable zinc compositions for oral absorption |
| JPH03220116A (en) * | 1990-01-03 | 1991-09-27 | Johnson & Johnson Consumer Prod Inc | Stable zinc composition for buccal use |
| JPH0597668A (en) * | 1991-04-12 | 1993-04-20 | Unilever Nv | Treatment of gum inflammation |
| JPH07165544A (en) * | 1993-12-14 | 1995-06-27 | Lion Corp | Oral composition |
| JPH08504816A (en) * | 1992-12-18 | 1996-05-28 | ザ、プロクター、エンド、ギャンブル、カンパニー | Oral composition containing antiplaque and anticalculus agent |
| JPH08505843A (en) * | 1992-12-18 | 1996-06-25 | ザ、プロクター、エンド、ギャンブル、カンパニー | Oral composition containing antiplaque and anticalculus agent |
-
1998
- 1998-02-27 JP JP10063992A patent/JPH11246376A/en active Pending
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5793987A (en) * | 1980-09-22 | 1982-06-11 | Richiyaadosonnbitsukusu Inc | Zinc derivatives and use for dental composition |
| US5002970A (en) * | 1981-07-31 | 1991-03-26 | Eby Iii George A | Flavor masked ionizable zinc compositions for oral absorption |
| JPS61263912A (en) * | 1985-04-16 | 1986-11-21 | コルゲ−ト・パ−モリブ・カンパニ− | Composition for drowning breath odor |
| JPS62223109A (en) * | 1986-01-22 | 1987-10-01 | コルゲ−ト・パ−モリブ・カンパニ− | Stable unit dosage type oral product |
| JPS638324A (en) * | 1986-06-27 | 1988-01-14 | Lion Corp | Composition for oral cavity |
| JPS6345215A (en) * | 1986-06-27 | 1988-02-26 | ブレンダツクス−ヴエルケ エル シユナイダ− ゲゼルシヤフト ミツト ベシユレンクテル ハフツンク ウント コンパニ− | Oral sanitary composition |
| JPS6366115A (en) * | 1986-09-09 | 1988-03-24 | Lion Corp | Composition for oral cavity for deodorizing nicotine |
| JPS63141921A (en) * | 1986-12-04 | 1988-06-14 | Kao Corp | Composition for oral cavity application |
| JPS6438017A (en) * | 1987-06-30 | 1989-02-08 | Union Carbide Corp | Anticaries and antitartar composition containing zeolitic zinc cation |
| JPH02223511A (en) * | 1988-11-09 | 1990-09-05 | Procter & Gamble Co:The | Composition for buccal application |
| JPH03220116A (en) * | 1990-01-03 | 1991-09-27 | Johnson & Johnson Consumer Prod Inc | Stable zinc composition for buccal use |
| JPH0597668A (en) * | 1991-04-12 | 1993-04-20 | Unilever Nv | Treatment of gum inflammation |
| JPH08504816A (en) * | 1992-12-18 | 1996-05-28 | ザ、プロクター、エンド、ギャンブル、カンパニー | Oral composition containing antiplaque and anticalculus agent |
| JPH08505843A (en) * | 1992-12-18 | 1996-06-25 | ザ、プロクター、エンド、ギャンブル、カンパニー | Oral composition containing antiplaque and anticalculus agent |
| JPH07165544A (en) * | 1993-12-14 | 1995-06-27 | Lion Corp | Oral composition |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006160621A (en) * | 2004-12-03 | 2006-06-22 | Naris Cosmetics Co Ltd | Oral composition for skin |
| US10537506B2 (en) | 2014-12-01 | 2020-01-21 | Colgate-Palmolive Company | Increasing micro-robustness |
| JP2017052700A (en) * | 2015-09-07 | 2017-03-16 | ライオン株式会社 | Oral composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR890002946B1 (en) | Oral hygine compositions | |
| CA2329622C (en) | Remineralizing oral compositions comprising palatinit | |
| JP4482270B2 (en) | Oral composition | |
| CA2013066A1 (en) | Compositions | |
| JP2002029950A (en) | Oral composition containing zinc compound | |
| WO2003103618A1 (en) | Compositions for oral cavity | |
| JPH11228368A (en) | Composition for oral cavity | |
| JPH02286613A (en) | New composition | |
| EP1459733B1 (en) | Oral care composition | |
| JP5398102B2 (en) | Oral or throat bactericidal composition | |
| JP2000281545A (en) | Composition for oral cavity | |
| JPH11246375A (en) | Composition for oral cavity | |
| JPH10501265A (en) | Mouth rinse composition | |
| JP3987593B2 (en) | Oral composition containing sodium chloride and magnesium chloride | |
| JP2001031542A (en) | Composition for oral cavity | |
| JPH11322554A (en) | Composition for oral cavity | |
| JP2003073282A (en) | Composition for oral cavity application | |
| JP4632553B2 (en) | Oral composition | |
| JPH11246376A (en) | Composition for oral cavity | |
| JP3582571B2 (en) | Oral liquid preparation | |
| JP2002047158A (en) | Dentifrice composition | |
| JP3491027B2 (en) | Oral composition | |
| JP3511727B2 (en) | Oral composition | |
| JP2004203894A (en) | Composition for oral cavity | |
| JP2000319148A (en) | Oral care composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040123 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040210 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040409 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040409 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20040409 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040409 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050308 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050509 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20050601 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20050704 |
|
| A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20060217 |